Effects of cell-type-specific expression of a pan-caspase inhibitor on renal fibrogenesis

被引:3
|
作者
Inoue, Tsutomu [1 ,2 ]
Kusano, Takeru [2 ,3 ]
Tomori, Kouji [1 ]
Nakamoto, Hidetomo [3 ]
Suzuki, Hiromichi [1 ,2 ]
Okada, Hirokazu [1 ,2 ,3 ]
机构
[1] Saitama Med Univ, Fac Med, Dept Nephrol, Moroyama, Saitama 3500451, Japan
[2] Saitama Med Univ, Res Ctr Genom Med, Project Res Div, Saitama 3501298, Japan
[3] Saitama Med Univ, Dept Gen Internal Med, Fac Med, Moroyama, Saitama 3500451, Japan
关键词
Caspase; p35; Apoptosis; Inflammasome; Inflammation; Fibrogenesis; ISCHEMIA-REPERFUSION INJURY; URETERAL OBSTRUCTION; SYSTEMIC-SCLEROSIS; TISSUE FIBROSIS; KIDNEY-DISEASE; APOPTOSIS; INFLAMMATION; FIBROBLASTS; EPITHELIUM; RECEPTOR;
D O I
10.1007/s10157-014-1011-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The caspase family of enzymes is grouped into two major sub-families, namely apoptotic and inflammatory caspases, which play central roles in the induction of apoptosis, regulation of inflammation and immunity, and cellular differentiation. The role of caspase activation in tubular epithelium and interstitial cells of 3 lines of transgenic mice with obstructed nephropathy was examined: p35 mice bearing the pan-caspase inhibitor protein expressed by the p35 gene separated from the universal CAG promoter by a floxed STOP sequence were crossed with gamma GT.Cre and FSP1.Cre mice that express Cre recombinase in the cortical tubular epithelium and FSP1(+) interstitial cells, respectively. The gamma GT.Cre;p35, FSP1.Cre;p35 and p35 control mice were then challenged with unilateral ureter obstruction (UUO). Proinflammatory parameters such as protein levels of active IL-1 beta subunit and mRNA levels of TNF-alpha and NOD-like receptor pyrin domain containing-3, and profibrogenic parameters such as interstitial matrix deposition and mRNA levels of fibronectin EIIIA isoform and alpha 1 chain of procollagen type I in the kidneys were significantly increased at 7 days in the FSP1.Cre;p35- and p35-UUO mice, but not in the gamma GT.Cre;p35-UUO mice. These changes paralleled the numbers of apoptotic nuclei in tubules, but not in interstitial cells, and the protein levels of active caspase-3 subunit in the kidneys of FSP1.Cre;p35-, p35- and gamma GT.Cre;p35-UUO mice. This study provides evidence of the critical role of caspase activation in the tubular epithelium, but not in FSP1(+) interstitial cells, in apoptosis and inflammasome induction, leading to proinflammatory and profibrogenic processes in fibrous kidneys with UUO.
引用
收藏
页码:350 / 358
页数:9
相关论文
共 50 条
  • [21] Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury
    Baskin-Bey, E. S.
    Washburn, K.
    Feng, S.
    Oltersdorf, T.
    Shapiro, D.
    Huyghe, MiRa
    Burgart, L.
    Garrity-Park, M.
    van Vilsteren, F. G. I.
    Oliver, L. K.
    Rosen, C. B.
    Gores, G. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (01) : 218 - 225
  • [22] Anti-apoptotic effects of pan-caspase inhibitor (Z-VAD), SOD or catalase on antimycin A-induced HeLa cell death
    Han, Yong Hwan
    Kim, Suhn Hee
    Kim, Sung Zoo
    Park, Woo Hyun
    MOLECULAR MEDICINE REPORTS, 2009, 2 (02) : 307 - 311
  • [23] ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19.
    Alpan, O.
    Gupta, R.
    Latterich, M.
    Hubka, M.
    Bukhari, Z.
    Ndhlovu, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S15 - S16
  • [24] Radioprotective effect of a pan-caspase inhibitor in a novel model of radiation injury to the nucleus of the abducens nerve
    Li, Jianguo
    Lin, Li
    Du, Liqing
    Xu, Chang
    Wang, Yan
    Cao, Jia
    Wang, Qin
    Fan, Feiyue
    Wang, Xiaoping
    Wang, Yafei
    Liu, Qiang
    MOLECULAR MEDICINE REPORTS, 2014, 10 (03) : 1433 - 1437
  • [25] Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3
    Martin, Ulrike
    Jarasch, Nadine
    Nestler, Matthias
    Rassmann, Alexander
    Munder, Thomas
    Seitz, Simone
    Zell, Roland
    Wutzler, Peter
    Henke, Andreas
    APOPTOSIS, 2007, 12 (03) : 525 - 533
  • [26] Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3
    Ulrike Martin
    Nadine Jarasch
    Matthias Nestler
    Alexander Rassmann
    Thomas Munder
    Simone Seitz
    Roland Zell
    Peter Wutzler
    Andreas Henke
    Apoptosis, 2007, 12 : 525 - 533
  • [27] Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
    Witek, Rafal P.
    Stone, W. Carl
    Karaca, F. Gamze
    Syn, Wing-Kin
    Pereira, Thiago A.
    Agboola, Kolade M.
    Omenetti, Alessia
    Jung, Youngmi
    Teaberry, Vanessa
    Choi, Steve S.
    Guy, Cynthia D.
    Pollard, John
    Charlton, Peter
    Diehl, Anna Mae
    HEPATOLOGY, 2009, 50 (05) : 1421 - 1430
  • [28] Pan-caspase inhibitor protects against noise-induced hearing loss in a rodent model
    Yepes, Maria Fernanda
    Minesinger, Kayla
    Raciti, Federica M.
    Salazar, Maria Camila
    Rajguru, Suhrud M.
    FRONTIERS IN NEUROSCIENCE, 2025, 19
  • [29] Atlas of primary cell-type-specific sequence models of gene expression and variant effects
    Sokolova, Ksenia
    Theesfeld, Chandra L.
    Wong, Aaron K.
    Zhang, Zijun
    Dolinski, Kara
    Troyanskaya, Olga G.
    CELL REPORTS METHODS, 2023, 3 (09):
  • [30] Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?
    Khurana, Sandeep
    Khara, Harshit S.
    HEPATOLOGY, 2019, 70 (03) : 1078 - 1079